DRL launches nitroglycerin sublingual tablets in US
The drug which is used in preventing or relieving a sudden attack of angina (chest pain) caused by heart disease was approved by the USFDA.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Cardiology | Heart | Heart Disease | Nitroglycerin | Pain | Pharmaceuticals